Evidence map›Paper›PMID 31974356›Full record

ArticleCell death & disease2020

Correction: TNFR2 induced priming of the inflammasome leads to a RIPK1-dependent cell death in the absence of XIAP.

Janin Knop, Lisanne M Spilgies, Stefanie Rufli, Ramona Reinhart, Lazaros Vasilikos, Monica Yabal, Erika Owsley, Philipp J Jost, Rebecca A Marsh, Harald Wajant and 3 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell death & disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Janin Knop *Institute of Experimental Immunology, University of Zürich, Zürich, Switzerland.
Lisanne M Spilgies *Institute of Experimental Immunology, University of Zürich, Zürich, Switzerland.
Stefanie RufliInstitute of Experimental Immunology, University of Zürich, Zürich, Switzerland.
Ramona ReinhartInstitute of Pharmacology, University of Bern, Bern, Switzerland.
Lazaros VasilikosInstitute of Experimental Immunology, University of Zürich, Zürich, Switzerland.
Monica YabalIII. Medizinische Klink, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.
Erika OwsleyUC Department of Pediatrics, Cincinnati Children's Hospital, Cincinnati, USA.
Philipp J JostIII. Medizinische Klink, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.ORCID http://orcid.org/0000-0003-2454-0362
Rebecca A MarshUC Department of Pediatrics, Cincinnati Children's Hospital, Cincinnati, USA.
Harald WajantDivision of Molecular Internal Medicine, Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.
Mark D RobinsonInstitute of Molecular Life Sciences and SIB Swiss Institute of Bioinformatics, University of Zürich, Zürich, Switzerland.
Thomas KaufmannInstitute of Pharmacology, University of Bern, Bern, Switzerland.ORCID http://orcid.org/0000-0001-9906-874X
W Wei-Lynn WongInstitute of Experimental Immunology, University of Zürich, Zürich, Switzerland. wong@immunology.uzh.ch.ORCID http://orcid.org/0000-0003-3155-1211

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The original version of this article contained an error in the name of one of the co-authors (Erika Owsley). This has been corrected in the PDF and HTML versions.

Identifiers

PMID31974356
PMCPMC6978449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.